Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BIO4 Bone Matrix in ACDF Surgery
NCT03077204Phase 4Completed
- Sponsor
- Ascension Seton
- Start
- Apr 2017
- Primary completion
- Jan 2020
- Modality
- Cell Therapies, Device-based Delivery
- Countries
- 1
01
Overview
A Phase 4 trial of BIO4 in degenerative disc disease (DDD), Spinal cord injury (SCI), spondylolisthesis, spinal stenosis, pseudoarthrosis, sponsored by Ascension Seton. Started Apr 2017; status: completed.
02
Drugs
BIO4
03
Conditions
degenerative disc disease (DDD)Spinal cord injury (SCI)spondylolisthesisspinal stenosispseudoarthrosis
Beyond the preview
Go deeper on NCT03077204.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03077204.